bc

Generic: aspirin and caffeine

Labeler: medtech products inc.
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name bc
Generic Name aspirin and caffeine
Labeler medtech products inc.
Dosage Form POWDER
Routes
ORAL
Active Ingredients

aspirin 845 mg/1, caffeine 65 mg/1

Manufacturer
Medtech Products Inc.

Identifiers & Regulatory

Product NDC 63029-992
Product ID 63029-992_f5d06b48-7741-490d-b6f8-7cd21f906401
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2026-12-31
Marketing Start 2012-06-01

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc] central nervous system stimulant [epc] methylxanthine [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs] xanthines [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe] central nervous system stimulation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 63029992
Hyphenated Format 63029-992

Supplemental Identifiers

RxCUI
994435 1247402
UNII
R16CO5Y76E 3G6A5W338E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832 N0000175739 N0000175729 N0000175790 M0023046

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bc (source: ndc)
Generic Name aspirin and caffeine (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 845 mg/1
  • 65 mg/1
source: ndc
Packaging
  • 2 POWDER in 1 PACKAGE (63029-992-02)
  • 6 POWDER in 1 PACKAGE (63029-992-06)
  • 18 POWDER in 1 BOX (63029-992-18)
  • 24 POWDER in 1 BOX (63029-992-24)
  • 50 POWDER in 1 BOX (63029-992-50)
source: ndc

Packages (5)

Ingredients (2)

aspirin (845 mg/1) caffeine (65 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f5d06b48-7741-490d-b6f8-7cd21f906401", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "3G6A5W338E"], "rxcui": ["994435", "1247402"], "spl_set_id": ["226173d4-b6d5-4fe6-b24e-1cc5d1b31c88"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Medtech Products Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 POWDER in 1 PACKAGE (63029-992-02)", "package_ndc": "63029-992-02", "marketing_start_date": "20120601"}, {"sample": false, "description": "6 POWDER in 1 PACKAGE (63029-992-06)", "package_ndc": "63029-992-06", "marketing_start_date": "20120601"}, {"sample": false, "description": "18 POWDER in 1 BOX (63029-992-18)", "package_ndc": "63029-992-18", "marketing_start_date": "20120601"}, {"sample": false, "description": "24 POWDER in 1 BOX (63029-992-24)", "package_ndc": "63029-992-24", "marketing_start_date": "20120601"}, {"sample": false, "description": "50 POWDER in 1 BOX (63029-992-50)", "package_ndc": "63029-992-50", "marketing_start_date": "20120601"}], "brand_name": "BC", "product_id": "63029-992_f5d06b48-7741-490d-b6f8-7cd21f906401", "dosage_form": "POWDER", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "63029-992", "generic_name": "Aspirin and Caffeine", "labeler_name": "Medtech Products Inc.", "product_type": "HUMAN OTC DRUG", "brand_name_base": "BC", "active_ingredients": [{"name": "ASPIRIN", "strength": "845 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20120601", "listing_expiration_date": "20261231"}